GSE212231 GSE218491 SHP2 inhibition 3 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE212231_GSE218491_SHP2 inhibition_3_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE212231_GSE218491_SHP2 inhibition_3_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE212231_GSE218491_SHP2 inhibition_3_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE212231_GSE218491_SHP2 inhibition_3_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 3040

Gene

P2Y receptor family member 8

Gene

long intergenic non-protein coding RNA 3219

Gene

DHRS4 antisense RNA 1

Gene

TTN antisense RNA 1

Gene

ZFHX3 antisense RNA 1

Gene

PDCD6IP pseudogene 2

Gene

ULK4 pseudogene 1

Gene

nuclear factor, erythroid 4

Gene

long intergenic non-protein coding RNA 3021

  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    P2Y receptor family member 8


  • Gene

    long intergenic non-protein coding RNA 3219


  • Gene

    DHRS4 antisense RNA 1


  • Gene

    TTN antisense RNA 1


  • Gene

    ZFHX3 antisense RNA 1


  • Gene

    PDCD6IP pseudogene 2


  • Gene

    ULK4 pseudogene 1


  • Gene

    nuclear factor, erythroid 4


  • Gene

    long intergenic non-protein coding RNA 3021

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.